Search Results

The Role of Nanoparticle Morphology on Enhancing Delivery of Budesonide for Treatment of Inflammatory Bowel Disease.

• Authors : Li Q; Key Laboratory of Smart Drug Delivery of MOE, School of Pharmacy, Fudan University, Shanghai 201203, China.; Liu W

Subjects: Budesonide*/Budesonide*/Budesonide*/chemistry ; Budesonide*/Budesonide*/Budesonide*/administration & dosage ; Budesonide*/Budesonide*/Budesonide*/therapeutic use

• Source: ACS applied materials & interfaces [ACS Appl Mater Interfaces] 2024 Jul 03; Vol. 16 (26), pp. 33081-33092. Date of Electronic Publication: 2024 Jun 18.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101504991 Publication Model: Print-Electronic

Record details

Enteric-Coated Capsules Providing Reliable Site-Specific Drug Delivery to the Distal Ileum.

• Authors : Grimm M; Institute of Pharmacy, University of Greifswald, Greifswald 17487, Germany.; Großmann L

Subjects: Ileum*/Ileum*/Ileum*/metabolism ; Ileum*/Ileum*/Ileum*/drug effects ; Drug Delivery Systems*/Drug Delivery Systems*/Drug Delivery Systems*/methods

• Source: Molecular pharmaceutics [Mol Pharm] 2024 Jun 03; Vol. 21 (6), pp. 2828-2837. Date of Electronic Publication: 2024 May 09.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic

Record details

Controlled Pulmonary Delivery of Carrier-Free Budesonide Dry Powder by Atomic Layer Deposition.

• Authors : La Zara D; Department of Chemical Engineering, Delft University of Technology, Van der Maasweg 9, Delft, 2629HZ, The Netherlands.; Sun F

Subjects: Budesonide* ; Silicon Dioxide*; Administration, Inhalation

• Source: ACS nano [ACS Nano] 2021 Apr 27; Vol. 15 (4), pp. 6684-6698. Date of Electronic Publication: 2021 Mar 26.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101313589 Publication Model: Print-Electronic

Record details

Characterization of Membrane-Type Dissolution Profiles of Clinically Available Orally Inhaled Products Using a Weibull Fit and a Mechanistic Model.

• Authors : van der Zwaan I; Department of Pharmaceutical Biosciences and the Swedish Drug Delivery Center (SweDeliver), Uppsala University, P.O. Box 580, 751 23 Uppsala, Sweden.; Franek F

Subjects: Budesonide*; Administration, Inhalation ; Fluticasone

• Source: Molecular pharmaceutics [Mol Pharm] 2022 Sep 05; Vol. 19 (9), pp. 3114-3124. Date of Electronic Publication: 2022 Aug 08.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic

Record details

Novel Pyrrolidine Derivatives of Budesonide as Long Acting Inhaled Corticosteroids for the Treatment of Pulmonary Inflammatory Diseases.

• Authors : Ghidini E; Marchini G; Capelli AM

Subjects: Drug Design*; Adrenal Cortex Hormones/Adrenal Cortex Hormones/Adrenal Cortex Hormones/*chemistry ; Adrenal Cortex Hormones/Adrenal Cortex Hormones/Adrenal Cortex Hormones/*pharmacology

• Source: Journal of medicinal chemistry [J Med Chem] 2018 Jun 14; Vol. 61 (11), pp. 4757-4773. Date of Electronic Publication: 2018 May 24.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic

Record details

Development of Novel Glucocorticoids for Use in Antibody-Drug Conjugates for the Treatment of Inflammatory Diseases.

• Authors : Han A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York 10591, United States.; Olsen O

Subjects: Budesonide/Budesonide/Budesonide/*analogs & derivatives ; Budesonide/Budesonide/Budesonide/*therapeutic use ; Glucocorticoids/Glucocorticoids/Glucocorticoids/*therapeutic use

• Source: Journal of medicinal chemistry [J Med Chem] 2021 Aug 26; Vol. 64 (16), pp. 11958-11971. Date of Electronic Publication: 2021 Aug 11.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic

Record details

Mono- and Cocultures of Bronchial and Alveolar Epithelial Cells Respond Differently to Proinflammatory Stimuli and Their Modulation by Salbutamol and Budesonide.

• Authors : Haghi M; †Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), 66123 Saarbrücken, Germany.; ‡School of Pharmacy, Graduate School of Health, The University of Technology Sydney, New South Wales 2007, Australia.

Subjects: Albuterol/Albuterol/Albuterol/*pharmacology ; Bronchi/Bronchi/Bronchi/*cytology ; Budesonide/Budesonide/Budesonide/*pharmacology

• Source: Molecular pharmaceutics [Mol Pharm] 2015 Aug 03; Vol. 12 (8), pp. 2625-32. Date of Electronic Publication: 2015 Jul 06.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic

Record details

Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy.

• Authors : López-Cerdá, Sandra; Molinaro, Giuseppina; Tello, Rubén Pareja

• Source: ACS Applied Materials & Interfaces; 4/17/2024, Vol. 16 Issue 15, p18643-18657, 15p

Record details

Endotracheal Aerosolization Device for Laboratory Investigation of Pulmonary Delivery of Nanoparticle Suspensions: In Vitro and in Vivo Validation.

• Authors : Huang Z; School of Pharmaceutical Sciences , Sun Yat-Sen University , Guangzhou , 510006 Guangdong , P. R. China.; Huang Y

Subjects: Nebulizers and Vaporizers*; Budesonide/Budesonide/Budesonide/*administration & dosage ; Drug Carriers/Drug Carriers/Drug Carriers/*chemistry

• Source: Molecular pharmaceutics [Mol Pharm] 2018 Dec 03; Vol. 15 (12), pp. 5521-5533. Date of Electronic Publication: 2018 Nov 20.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic

Record details

Polymer-Lipid Microparticles for Pulmonary Delivery.

• Authors : Eleftheriadis GK; Laboratory of Pharmaceutical Technology, School of Pharmacy , Aristotle University of Thessaloniki , 54124 Thessaloniki , Greece.; Akrivou M

Subjects: Budesonide/Budesonide/Budesonide/*chemistry ; Drug Carriers/Drug Carriers/Drug Carriers/*chemistry ; Excipients/Excipients/Excipients/*chemistry

• Source: Langmuir : the ACS journal of surfaces and colloids [Langmuir] 2018 Mar 20; Vol. 34 (11), pp. 3438-3448. Date of Electronic Publication: 2018 Mar 09.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9882736 Publication Model: Print-Electronic

Record details